Glucovance, a new tablet that combines glyburide and metformin

September 2000

Bristol-Myers Squibb is now marketing Glucovance, a new tablet that combines glyburide and metformin.

Many patients take metformin and a sulfonylurea for diabetes. These drugs have additive effects to lower blood sugar.

The combination can lower HbA1c by 1.5% to 3.5%...depending on how high the patient's HbA1c is when they start the drug.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote